Page last updated: 2024-09-03

sk&f 95654 and isoproterenol

sk&f 95654 has been researched along with isoproterenol in 1 studies

Compound Research Comparison

Studies
(sk&f 95654)
Trials
(sk&f 95654)
Recent Studies (post-2010)
(sk&f 95654)
Studies
(isoproterenol)
Trials
(isoproterenol)
Recent Studies (post-2010) (isoproterenol)
80130,7808032,640

Protein Interaction Comparison

ProteinTaxonomysk&f 95654 (IC50)isoproterenol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.246
Beta-1 adrenergic receptorHomo sapiens (human)0.333
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)1.77
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-2 adrenergic receptorCanis lupus familiaris (dog)0.6667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dormer, RL; Lloyd Mills, C; McPherson, MA; Murray, KJ; Pereira, MM1

Other Studies

1 other study(ies) available for sk&f 95654 and isoproterenol

ArticleYear
A cyclic nucleotide PDE5 inhibitor corrects defective mucin secretion in submandibular cells containing antibody directed against the cystic fibrosis transmembrane conductance regulator protein.
    FEBS letters, 1999, Dec-24, Volume: 464, Issue:1-2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antibodies; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Isoproterenol; Mucins; Purinones; Pyridazines; Pyridines; Rats; Rolipram; Submandibular Gland

1999